Aoran Dong

1PUBLICATIONS
1CO-AUTHORS
Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

|Nov 10, 2020
PD-L1 versus tumor mutation burden: Which is the better immunotherapy biomarker in advanced non-small cell lung cancer?

Aoran Dong, Yiming Zhao, Zhihua Li

Pageof 1

Frequent Collaborators

1 joint publications

Hai Hu